TrialBritish journal of clinical pharmacology2005

Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate.

Paul Snell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.